Found: 6 articles
Article | Edition |
---|---|
V.V. Borisov
Overactive bladder – pathogenetic features and choice of drug therapy
|
№2 / 2021 |
Yu.A. Kupriyanov, G.R. Kasyan, D.Yu. Pushkar
A role of fesoterodine in treatment of overactive bladder
|
№6 / 2018 |
Yu.B. Kazilov, Z.K. Gadzhieva
Prevalence of various voiding disorders
|
№5 / 2016 |
G.G. Krivoborodov, E.I. Tur
Validation of urgency scale to detect and assess urgency in patients with overactive bladder
|
№2 (supplement) / 2016 |
G.G. Krivoborodov, E.F. Kolesanova, E.I. Tur, N.S. Efremov
Nerve growth factor in the urine of patients with idiopathic detrusor overactivity and overactive bladder without detrusor overactivity
|
№3 / 2015 |
Ibinayeva I.S., Apolikhina I.A., Makhmedzhanova F.N., Muslimova S.Z.
Solifenacin in the treatment of patients with overactive bladder: results of a randomized, double-blind, placebo-plans-controlled trial with increasing doses of the drug
|
№5 / 2012 |